$GYHT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in HALOZYME THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in HALOZYME THERAPEUTICS, INC.. Get notifications about new insider transactions in HALOZYME THERAPEUTICS, INC. for free.
Page: < prev 1 2 3 4 5 6 7 ... 15 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 05 2018 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Buy | M | 0.00 | 23,120 | 0 | 48,322 | 25.2 K to 48.3 K (+91.74 %) |
Feb 05 2018 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | M | 0.00 | 55,487 | 0 | 110,974 | |
Feb 05 2018 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Payment of Exercise | F | 18.37 | 24,111 | 442,919 | 293,886 | 318 K to 293.9 K (-7.58 %) |
Feb 05 2018 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Buy | M | 0.00 | 55,487 | 0 | 317,997 | 262.5 K to 318 K (+21.14 %) |
Jan 09 2018 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | M | 0.00 | 30,000 | 0 | 0 | |
Jan 09 2018 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Payment of Exercise | F | 19.46 | 11,649 | 226,690 | 262,510 | 274.2 K to 262.5 K (-4.25 %) |
Jan 09 2018 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Buy | M | 0.00 | 30,000 | 0 | 274,159 | 244.2 K to 274.2 K (+12.29 %) |
Sep 21 2017 | GYHT | HALOZYME THERAPEUT ... | MATSUI CONNIE | Director | Gift | G | 0.00 | 15,000 | 0 | 232,388 | 247.4 K to 232.4 K (-6.06 %) |
Jul 26 2017 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | Director | Buy | J | 0.00 | 2,327,603 | 0 | 2,327,603 | 0 to 2.3 M |
Jul 26 2017 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | Director | Buy | J | 0.00 | 2,264,483 | 0 | 5,321,084 | 3.1 M to 5.3 M (+74.09 %) |
Jul 26 2017 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | Director | Sell | J | 0.00 | 6,328,853 | 0 | 0 | 6.3 M to 0 (-100.00 %) |
Jun 16 2017 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Option Exercise | M | 0.00 | 6,875 | 0 | 13,750 | |
Jun 16 2017 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Payment of Exercise | F | 13.05 | 2,583 | 33,708 | 25,202 | 27.8 K to 25.2 K (-9.30 %) |
Jun 16 2017 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Buy | M | 0.00 | 6,875 | 0 | 27,785 | 20.9 K to 27.8 K (+32.88 %) |
May 15 2017 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | Director | Option Exercise | M | 10.37 | 10,000 | 103,700 | 0 | |
May 15 2017 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | Director | Buy | M | 10.37 | 10,000 | 103,700 | 3,562,388 | 3.6 M to 3.6 M (+0.28 %) |
May 09 2017 | GYHT | HALOZYME THERAPEUT ... | MATSUI CONNIE | Director | Option Exercise | M | 10.37 | 10,000 | 103,700 | 0 | |
May 09 2017 | GYHT | HALOZYME THERAPEUT ... | MATSUI CONNIE | Director | Buy | M | 10.37 | 10,000 | 103,700 | 247,388 | 237.4 K to 247.4 K (+4.21 %) |
May 08 2017 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | Director | Grant | A | 0.00 | 14,135 | 0 | 3,552,388 | 3.5 M to 3.6 M (+0.40 %) |
May 05 2017 | GYHT | HALOZYME THERAPEUT ... | Posard Matthew L. | Director | Grant | A | 0.00 | 14,135 | 0 | 92,388 | 78.3 K to 92.4 K (+18.06 %) |
May 05 2017 | GYHT | HALOZYME THERAPEUT ... | MATSUI CONNIE | Director | Grant | A | 0.00 | 14,135 | 0 | 237,388 | 223.3 K to 237.4 K (+6.33 %) |
May 05 2017 | GYHT | HALOZYME THERAPEUT ... | Kelley Kenneth J | Director | Grant | A | 0.00 | 14,135 | 0 | 202,388 | 188.3 K to 202.4 K (+7.51 %) |
May 05 2017 | GYHT | HALOZYME THERAPEUT ... | Henderson Jeffrey William | Director | Grant | A | 0.00 | 14,135 | 0 | 40,742 | 26.6 K to 40.7 K (+53.13 %) |
May 05 2017 | GYHT | HALOZYME THERAPEUT ... | Daly James M | Director | Grant | A | 0.00 | 14,135 | 0 | 34,337 | 20.2 K to 34.3 K (+69.97 %) |
May 05 2017 | GYHT | HALOZYME THERAPEUT ... | BIZZARI JEAN-PIERRE | Director | Grant | A | 0.00 | 14,135 | 0 | 50,949 | 36.8 K to 50.9 K (+38.40 %) |
Apr 14 2017 | GYHT | HALOZYME THERAPEUT ... | LEONHARDT HARRY J | SVP, GC and CCO | Option Exercise | M | 0.00 | 6,875 | 0 | 13,750 | |
Apr 14 2017 | GYHT | HALOZYME THERAPEUT ... | LEONHARDT HARRY J | SVP, GC and CCO | Payment of Exercise | F | 12.81 | 2,583 | 33,088 | 17,799 | 20.4 K to 17.8 K (-12.67 %) |
Apr 14 2017 | GYHT | HALOZYME THERAPEUT ... | LEONHARDT HARRY J | SVP, GC and CCO | Buy | M | 0.00 | 6,875 | 0 | 20,382 | 13.5 K to 20.4 K (+50.90 %) |
Feb 24 2017 | GYHT | HALOZYME THERAPEUT ... | LEONHARDT HARRY J | SVP, GC and CCO | Option Exercise | A | 0.00 | 45,568 | 0 | 45,568 | |
Feb 24 2017 | GYHT | HALOZYME THERAPEUT ... | LEONHARDT HARRY J | SVP, GC and CCO | Option Exercise | A | 12.07 | 72,925 | 880,205 | 72,925 | |
Feb 24 2017 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Option Exercise | A | 0.00 | 45,568 | 0 | 45,568 | |
Feb 24 2017 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Option Exercise | A | 12.07 | 72,925 | 880,205 | 72,925 | |
Feb 24 2017 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | A | 0.00 | 157,416 | 0 | 157,416 | |
Feb 24 2017 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | A | 12.07 | 251,923 | 3,040,711 | 251,923 | |
Feb 07 2017 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | M | 0.00 | 31,250 | 0 | 62,500 | |
Feb 07 2017 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Buy | M | 0.00 | 31,250 | 0 | 244,159 | 212.9 K to 244.2 K (+14.68 %) |
Feb 06 2017 | GYHT | HALOZYME THERAPEUT ... | LEONHARDT HARRY J | SVP, GC and CCO | Option Exercise | M | 0.00 | 15,413 | 0 | 46,239 | |
Feb 06 2017 | GYHT | HALOZYME THERAPEUT ... | LEONHARDT HARRY J | SVP, GC and CCO | Payment of Exercise | F | 12.26 | 6,198 | 75,987 | 13,507 | 19.7 K to 13.5 K (-31.45 %) |
Feb 06 2017 | GYHT | HALOZYME THERAPEUT ... | LEONHARDT HARRY J | SVP, GC and CCO | Buy | M | 0.00 | 15,413 | 0 | 19,705 | 4.3 K to 19.7 K (+359.11 %) |
Feb 06 2017 | GYHT | HALOZYME THERAPEUT ... | Countouriotis Athena | SVP and Chief Medic ... | Option Exercise | M | 0.00 | 18,496 | 0 | 55,487 | |
Feb 06 2017 | GYHT | HALOZYME THERAPEUT ... | Countouriotis Athena | SVP and Chief Medic ... | Payment of Exercise | F | 12.26 | 6,900 | 84,594 | 39,077 | 46 K to 39.1 K (-15.01 %) |
Feb 06 2017 | GYHT | HALOZYME THERAPEUT ... | Countouriotis Athena | SVP and Chief Medic ... | Buy | M | 0.00 | 18,496 | 0 | 45,977 | 27.5 K to 46 K (+67.30 %) |
Feb 06 2017 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Option Exercise | M | 0.00 | 23,120 | 0 | 69,358 | |
Feb 06 2017 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Payment of Exercise | F | 12.26 | 9,085 | 111,382 | 20,910 | 30 K to 20.9 K (-30.29 %) |
Feb 06 2017 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Buy | M | 0.00 | 23,120 | 0 | 29,995 | 6.9 K to 30 K (+336.29 %) |
Feb 06 2017 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | M | 0.00 | 55,487 | 0 | 166,461 | |
Feb 06 2017 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Buy | M | 0.00 | 55,487 | 0 | 212,909 | 157.4 K to 212.9 K (+35.25 %) |
Jan 09 2017 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | M | 0.00 | 30,000 | 0 | 30,000 | |
Jan 09 2017 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Buy | M | 0.00 | 30,000 | 0 | 157,422 | 127.4 K to 157.4 K (+23.54 %) |
Jan 09 2017 | GYHT | HALOZYME THERAPEUT ... | Countouriotis Athena | SVP and Chief Medic ... | Option Exercise | M | 0.00 | 7,500 | 0 | 15,000 | |
Jan 09 2017 | GYHT | HALOZYME THERAPEUT ... | Countouriotis Athena | SVP and Chief Medic ... | Buy | M | 0.00 | 7,500 | 0 | 27,481 | 20 K to 27.5 K (+37.54 %) |
Sep 02 2016 | GYHT | HALOZYME THERAPEUT ... | Gergen Mark J | SVP, Chief Operatin ... | Option Exercise | A | 9.97 | 333,890 | 3,328,883 | 333,890 | |
Jul 05 2016 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | M | 0.00 | 13,500 | 0 | 0 | |
Jul 05 2016 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | A | 0.00 | 13,500 | 0 | 13,500 | |
Jul 05 2016 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Payment of Exercise | F | 8.63 | 7,044 | 60,790 | 127,422 | 134.5 K to 127.4 K (-5.24 %) |
Jul 05 2016 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Buy | M | 0.00 | 13,500 | 0 | 134,466 | 121 K to 134.5 K (+11.16 %) |
Jul 05 2016 | GYHT | HALOZYME THERAPEUT ... | Countouriotis Athena | SVP and Chief Medic ... | Option Exercise | M | 0.00 | 6,450 | 0 | 0 | |
Jul 05 2016 | GYHT | HALOZYME THERAPEUT ... | Countouriotis Athena | SVP and Chief Medic ... | Option Exercise | A | 0.00 | 6,450 | 0 | 6,450 | |
Jul 05 2016 | GYHT | HALOZYME THERAPEUT ... | Countouriotis Athena | SVP and Chief Medic ... | Payment of Exercise | F | 8.63 | 107 | 923 | 19,981 | 20.1 K to 20 K (-0.53 %) |
Jul 05 2016 | GYHT | HALOZYME THERAPEUT ... | Countouriotis Athena | SVP and Chief Medic ... | Buy | M | 0.00 | 6,450 | 0 | 20,088 | 13.6 K to 20.1 K (+47.29 %) |
Jun 16 2016 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Option Exercise | M | 0.00 | 6,875 | 0 | 20,625 | |
Jun 16 2016 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Buy | M | 0.00 | 6,875 | 0 | 16,875 | 10 K to 16.9 K (+68.75 %) |
Jun 02 2016 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | Director | Buy | J | 0.00 | 21,858 | 0 | 21,858 | 0 to 21.9 K |
Jun 02 2016 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | Director | Buy | J | 0.00 | 65,572 | 0 | 65,572 | 0 to 65.6 K |
Jun 02 2016 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | Director | Buy | J | 0.00 | 131,144 | 0 | 131,144 | 0 to 131.1 K |
Jun 02 2016 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | Director | Buy | J | 0.00 | 4,382 | 0 | 46,701 | 42.3 K to 46.7 K (+10.35 %) |
Jun 02 2016 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | Director | Buy | J | 0.00 | 27,260 | 0 | 290,460 | 263.2 K to 290.5 K (+10.36 %) |
Jun 02 2016 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | Director | Buy | J | 0.00 | 2,235 | 0 | 2,235 | 0 to 2.2 K |
Jun 02 2016 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | Director | Buy | J | 0.00 | 23,259 | 0 | 354,653 | 331.4 K to 354.7 K (+7.02 %) |
Jun 02 2016 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | Director | Buy | J | 0.00 | 23,259 | 0 | 354,654 | 331.4 K to 354.7 K (+7.02 %) |
Jun 02 2016 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | Director | Buy | J | 0.00 | 9,954 | 0 | 302,954 | 293 K to 303 K (+3.40 %) |
Jun 02 2016 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | Director | Buy | J | 0.00 | 9,954 | 0 | 302,954 | 293 K to 303 K (+3.40 %) |
Jun 02 2016 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | Director | Buy | J | 0.00 | 9,954 | 0 | 302,954 | 293 K to 303 K (+3.40 %) |
Jun 02 2016 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | Director | Buy | J | 0.00 | 372 | 0 | 11,317 | 10.9 K to 11.3 K (+3.40 %) |
Jun 02 2016 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | Director | Buy | J | 0.00 | 371,186 | 0 | 3,056,601 | 2.7 M to 3.1 M (+13.82 %) |
Jun 02 2016 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | Director | Buy | J | 0.00 | 81,795 | 0 | 216,795 | 135 K to 216.8 K (+60.59 %) |
Jun 02 2016 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | Director | Sell | J | 0.00 | 1,326,320 | 0 | 0 | 1.3 M to 0 (-100.00 %) |
May 06 2016 | GYHT | HALOZYME THERAPEUT ... | MATSUI CONNIE | Director | Grant | A | 0.00 | 20,202 | 0 | 223,253 | 203.1 K to 223.3 K (+9.95 %) |
May 06 2016 | GYHT | HALOZYME THERAPEUT ... | Daly James M | Director | Grant | A | 0.00 | 20,202 | 0 | 20,202 | 0 to 20.2 K |
May 06 2016 | GYHT | HALOZYME THERAPEUT ... | Posard Matthew L. | Director | Grant | A | 0.00 | 20,202 | 0 | 78,253 | 58.1 K to 78.3 K (+34.80 %) |
May 06 2016 | GYHT | HALOZYME THERAPEUT ... | Kelley Kenneth J | Director | Grant | A | 0.00 | 20,202 | 0 | 188,253 | 168.1 K to 188.3 K (+12.02 %) |
May 06 2016 | GYHT | HALOZYME THERAPEUT ... | Henderson Jeffrey William | Director | Grant | A | 0.00 | 20,202 | 0 | 26,607 | 6.4 K to 26.6 K (+315.41 %) |
May 06 2016 | GYHT | HALOZYME THERAPEUT ... | FALBERG KATHRYN E | Director | Grant | A | 0.00 | 20,202 | 0 | 358,253 | 338.1 K to 358.3 K (+5.98 %) |
May 06 2016 | GYHT | HALOZYME THERAPEUT ... | BIZZARI JEAN-PIERRE | Director | Grant | A | 0.00 | 20,202 | 0 | 36,814 | 16.6 K to 36.8 K (+121.61 %) |
May 05 2016 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | Director | Grant | A | 0.00 | 20,202 | 0 | 3,538,253 | 3.5 M to 3.5 M (+0.57 %) |
Feb 09 2016 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | M | 0.00 | 31,250 | 0 | 93,750 | |
Feb 09 2016 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Payment of Exercise | F | 7.90 | 11,743 | 92,770 | 120,966 | 132.7 K to 121 K (-8.85 %) |
Feb 09 2016 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Buy | M | 0.00 | 31,250 | 0 | 132,709 | 101.5 K to 132.7 K (+30.80 %) |
Feb 04 2016 | GYHT | HALOZYME THERAPEUT ... | LEONHARDT HARRY J | SVP, GC and CCO | Option Exercise | A | 0.00 | 61,652 | 0 | 61,652 | |
Feb 04 2016 | GYHT | HALOZYME THERAPEUT ... | LEONHARDT HARRY J | SVP, GC and CCO | Option Exercise | A | 8.11 | 104,603 | 848,330 | 104,603 | |
Feb 04 2016 | GYHT | HALOZYME THERAPEUT ... | Countouriotis Athena | SVP and Chief Medic ... | Option Exercise | A | 0.00 | 73,983 | 0 | 73,983 | |
Feb 04 2016 | GYHT | HALOZYME THERAPEUT ... | Countouriotis Athena | SVP and Chief Medic ... | Option Exercise | A | 8.11 | 125,523 | 1,017,992 | 125,523 | |
Feb 04 2016 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Option Exercise | A | 92,478.00 | 92,478 | 8,552,180,484 | 92,478 | |
Feb 04 2016 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, Chief Financia ... | Option Exercise | A | 8.11 | 104,603 | 848,330 | 104,603 | |
Feb 04 2016 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | A | 0.00 | 221,948 | 0 | 221,948 | |
Feb 04 2016 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | A | 8.11 | 376,569 | 3,053,975 | 376,569 | |
Apr 14 2016 | GYHT | HALOZYME THERAPEUT ... | LEONHARDT HARRY J | SVP, GC and CCO | Option Exercise | M | 0.00 | 6,875 | 0 | 20,625 | |
Apr 14 2016 | GYHT | HALOZYME THERAPEUT ... | LEONHARDT HARRY J | SVP, GC and CCO | Payment of Exercise | F | 11.76 | 2,583 | 30,376 | 4,292 | 6.9 K to 4.3 K (-37.57 %) |
Apr 14 2016 | GYHT | HALOZYME THERAPEUT ... | LEONHARDT HARRY J | SVP, GC and CCO | Buy | M | 0.00 | 6,875 | 0 | 6,875 | 0 to 6.9 K |
Jan 14 2016 | GYHT | HALOZYME THERAPEUT ... | FALBERG KATHRYN E | Director | Option Exercise | M | 4.94 | 10,000 | 49,400 | 0 | |
Jan 14 2016 | GYHT | HALOZYME THERAPEUT ... | FALBERG KATHRYN E | Director | Option Exercise | M | 10.37 | 10,000 | 103,700 | 0 | |
Jan 14 2016 | GYHT | HALOZYME THERAPEUT ... | FALBERG KATHRYN E | Director | Buy | M | 4.94 | 10,000 | 49,400 | 338,051 | 328.1 K to 338.1 K (+3.05 %) |
Jan 14 2016 | GYHT | HALOZYME THERAPEUT ... | FALBERG KATHRYN E | Director | Buy | M | 10.37 | 10,000 | 103,700 | 328,051 | 318.1 K to 328.1 K (+3.14 %) |
Jan 07 2016 | GYHT | HALOZYME THERAPEUT ... | Countouriotis Athena | SVP and Chief Medic ... | Option Exercise | M | 0.00 | 7,500 | 0 | 22,500 | |
Jan 07 2016 | GYHT | HALOZYME THERAPEUT ... | Countouriotis Athena | SVP and Chief Medic ... | Payment of Exercise | F | 16.39 | 3,257 | 53,382 | 13,638 | 16.9 K to 13.6 K (-19.28 %) |
Jan 07 2016 | GYHT | HALOZYME THERAPEUT ... | Countouriotis Athena | SVP and Chief Medic ... | Buy | M | 0.00 | 7,500 | 0 | 16,895 | 9.4 K to 16.9 K (+79.83 %) |
Jan 07 2016 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | M | 0.00 | 30,000 | 0 | 60,000 | |
Jan 07 2016 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Payment of Exercise | F | 15.77 | 11,686 | 184,288 | 101,459 | 113.1 K to 101.5 K (-10.33 %) |
Jan 07 2016 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Buy | M | 0.00 | 30,000 | 0 | 113,145 | 83.1 K to 113.1 K (+36.08 %) |
Jan 04 2016 | GYHT | HALOZYME THERAPEUT ... | Countouriotis Athena | SVP and Chief Medic ... | Payment of Exercise | F | 17.33 | 5,655 | 98,001 | 9,395 | 15.1 K to 9.4 K (-37.57 %) |
Jan 04 2016 | GYHT | HALOZYME THERAPEUT ... | Countouriotis Athena | SVP and Chief Medic ... | Grant | A | 0.00 | 15,050 | 0 | 15,050 | 0 to 15.1 K |
Jan 04 2016 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Payment of Exercise | F | 17.33 | 16,436 | 284,836 | 83,145 | 99.6 K to 83.1 K (-16.51 %) |
Jan 04 2016 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Grant | A | 0.00 | 31,500 | 0 | 99,581 | 68.1 K to 99.6 K (+46.27 %) |
Sep 15 2015 | GYHT | HALOZYME THERAPEUT ... | MATSUI CONNIE | Director | Option Exercise | M | 4.94 | 10,000 | 49,400 | 0 | |
Sep 15 2015 | GYHT | HALOZYME THERAPEUT ... | MATSUI CONNIE | Director | Option Exercise | M | 2.33 | 10,000 | 23,300 | 0 | |
Sep 15 2015 | GYHT | HALOZYME THERAPEUT ... | MATSUI CONNIE | Director | Buy | M | 4.94 | 10,000 | 49,400 | 203,051 | 193.1 K to 203.1 K (+5.18 %) |
Sep 15 2015 | GYHT | HALOZYME THERAPEUT ... | MATSUI CONNIE | Director | Buy | M | 2.33 | 10,000 | 23,300 | 193,051 | 183.1 K to 193.1 K (+5.46 %) |
Sep 01 2015 | GYHT | HALOZYME THERAPEUT ... | Kelley Kenneth J | Director | Option Exercise | M | 10.37 | 10,000 | 103,700 | 0 | |
Sep 01 2015 | GYHT | HALOZYME THERAPEUT ... | Kelley Kenneth J | Director | Buy | M | 10.37 | 10,000 | 103,700 | 208,051 | 198.1 K to 208.1 K (+5.05 %) |
Aug 24 2015 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | Chief Financial Off ... | Buy | P | 17.24 | 10,000 | 172,384 | 10,000 | 0 to 10 K |
Aug 07 2015 | GYHT | HALOZYME THERAPEUT ... | Henderson Jeffrey William | Director | Grant | A | 0.00 | 6,405 | 0 | 6,405 | 0 to 6.4 K |
Jun 22 2015 | GYHT | HALOZYME THERAPEUT ... | Kelley Kenneth J | Director | Sell | S | 21.00 | 20,000 | 420,000 | 198,051 | 218.1 K to 198.1 K (-9.17 %) |
Jun 16 2015 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, CFO | Option Exercise | A | 0.00 | 27,500 | 0 | 27,500 | |
Jun 16 2015 | GYHT | HALOZYME THERAPEUT ... | Stelzer Laurie | SVP, CFO | Option Exercise | A | 20.43 | 225,000 | 4,596,750 | 225,000 | |
Jun 09 2015 | GYHT | HALOZYME THERAPEUT ... | Kelley Kenneth J | Director | Option Exercise | M | 4.94 | 10,000 | 49,400 | 0 | |
Jun 09 2015 | GYHT | HALOZYME THERAPEUT ... | Kelley Kenneth J | Director | Buy | M | 4.94 | 10,000 | 49,400 | 218,051 | 208.1 K to 218.1 K (+4.81 %) |
May 08 2015 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | Director | Grant | A | 0.00 | 13,175 | 0 | 3,518,051 | 3.5 M to 3.5 M (+0.38 %) |
May 07 2015 | GYHT | HALOZYME THERAPEUT ... | FALBERG KATHRYN E | Director | Grant | A | 0.00 | 13,175 | 0 | 318,051 | 304.9 K to 318.1 K (+4.32 %) |
May 07 2015 | GYHT | HALOZYME THERAPEUT ... | MATSUI CONNIE | Director | Grant | A | 0.00 | 13,175 | 0 | 183,051 | 169.9 K to 183.1 K (+7.76 %) |
May 07 2015 | GYHT | HALOZYME THERAPEUT ... | Kelley Kenneth J | Director | Grant | A | 0.00 | 13,175 | 0 | 208,051 | 194.9 K to 208.1 K (+6.76 %) |
May 07 2015 | GYHT | HALOZYME THERAPEUT ... | Posard Matthew L. | Director | Grant | A | 0.00 | 13,175 | 0 | 58,051 | 44.9 K to 58.1 K (+29.36 %) |
May 07 2015 | GYHT | HALOZYME THERAPEUT ... | BIZZARI JEAN-PIERRE | Director | Grant | A | 0.00 | 13,175 | 0 | 16,612 | 3.4 K to 16.6 K (+383.33 %) |
Apr 15 2015 | GYHT | HALOZYME THERAPEUT ... | LEONHARDT HARRY J | SVP, GC and CCO | Option Exercise | A | 0.00 | 27,500 | 0 | 27,500 | |
Apr 15 2015 | GYHT | HALOZYME THERAPEUT ... | LEONHARDT HARRY J | SVP, GC and CCO | Option Exercise | A | 15.63 | 225,000 | 3,516,750 | 225,000 | |
Mar 09 2015 | GYHT | HALOZYME THERAPEUT ... | Kelley Kenneth J | Director | Sell | S | 15.33 | 40,000 | 613,380 | 194,876 | 234.9 K to 194.9 K (-17.03 %) |
Mar 05 2015 | GYHT | HALOZYME THERAPEUT ... | Kelley Kenneth J | Director | Buy | W | 0.00 | 40,000 | 0 | 234,876 | 194.9 K to 234.9 K (+20.53 %) |
Feb 06 2015 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | A | 0.00 | 125,000 | 0 | 125,000 | |
Feb 06 2015 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | A | 13.87 | 200,000 | 2,774,000 | 200,000 | |
Feb 06 2015 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | VP and Chief Financ ... | Option Exercise | M | 0.00 | 7,088 | 0 | 21,262 | |
Feb 06 2015 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | VP and Chief Financ ... | Option Exercise | A | 0.00 | 28,000 | 0 | 28,000 | |
Feb 06 2015 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | VP and Chief Financ ... | Option Exercise | A | 13.81 | 45,000 | 621,450 | 45,000 | |
Feb 06 2015 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | VP and Chief Financ ... | Payment of Exercise | F | 13.87 | 2,660 | 36,894 | 364,320 | 367 K to 364.3 K (-0.72 %) |
Feb 06 2015 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | VP and Chief Financ ... | Buy | M | 0.00 | 7,088 | 0 | 366,980 | 359.9 K to 367 K (+1.97 %) |
Feb 04 2015 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | VP and Chief Financ ... | Option Exercise | M | 0.00 | 2,213 | 0 | 4,424 | |
Feb 04 2015 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | VP and Chief Financ ... | Option Exercise | M | 0.00 | 3,125 | 0 | 3,125 | |
Feb 04 2015 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | VP and Chief Financ ... | Buy | M | 0.00 | 2,213 | 0 | 359,892 | 357.7 K to 359.9 K (+0.62 %) |
Feb 04 2015 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | VP and Chief Financ ... | Buy | M | 0.00 | 3,125 | 0 | 357,679 | 354.6 K to 357.7 K (+0.88 %) |
Jan 21 2015 | GYHT | HALOZYME THERAPEUT ... | BIZZARI JEAN-PIERRE | Director | Grant | A | 0.00 | 3,437 | 0 | 3,437 | 0 to 3.4 K |
Jan 06 2015 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Option Exercise | M | 0.00 | 30,000 | 0 | 90,000 | |
Jan 06 2015 | GYHT | HALOZYME THERAPEUT ... | Torley Helen | President and CEO | Payment of Exercise | F | 10.06 | 11,919 | 119,905 | 68,081 | 80 K to 68.1 K (-14.90 %) |